Illumina, Inc.

$124.33

$2.26(-1.79%)

Illumina, Inc.

ILMN

$124.33

$2.26(-1.79%)

Illumina, Inc.

ILMN

NASDAQ

$124.33

$2.26(-1.79%)

Chart

Upcoming Earnings

Next report date

May 14, 2026

Report period

Q2 2026

EPS Estimate

$1.06

Revenue Estimate

—

Key stats

52-Week Range$124.33

$68.70

$155.53

Market capitalization

$19.01B

Dividend yield (indicated)

0.00%

Price to earnings Ratio (TTM)

22.38

Basic EPS (TTM)

$5.47

Net income (TTM)

$850.00M

Revenue (TTM)

$4.34B

Avg. volume

2.01M

Beta (1Y)

1.50

Employees

8.97K

Market capitalization

$19.01B

Dividend yield (indicated)

0.00%

Price to earnings Ratio (TTM)

22.38

Basic EPS (TTM)

$5.47

Net income (TTM)

$850.00M

Revenue (TTM)

$4.34B

Avg. volume

2.01M

Beta (1Y)

1.50

Employees

8.97K

Screener Quick Check

About Illumina, Inc.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Jacob Thaysen

Website

www.illumina.com

Headquarters

5200 Illumina Way, San Diego, CA, 92122

IPO Date

2000-07-28

Identifiers

ISINUS4523271090

Description

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services...

Related Stocks

Labcorp Holdings Inc.

$263.00Mkt Cap: $21.80B

Healthcare

Medical - Equipment & Services

ISIN:US5049221055

Quest Diagnostics Incorporated

DGX

$195.26Mkt Cap: $21.72B

Healthcare

Medical - Diagnostics & Research

ISIN:US74834L1008

Dividend Overview

This company does not pay dividends

Financials

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate